Type 2 Diabetes

Not much is known about the relationship between oral contraceptives use and diabetes, but this untapped area got the spotlight during a session at the American Diabetes Association (ADA 2016) 76th Scientific Sessions in New Orleans, Louisiana.

Is health-related quality of life as important as a patient’s A1c? Presentations at the 2016 ADA meeting discussed this component of diabetes care.

Patients with type 1 diabetes can safely lower their blood glucose levels and hypoglycemia in a home setting with the dual hormone (glucagon and insulin) bionic pancreas, a new study revealed at the American Diabetes Association (ADA 2016) 76th Scientific Sessions in New Orleans, Louisiana.

A fair amount of women who are diagnosed with gestational diabetes take active measures to lose weight – but what clinical outcomes does that have?

Vitamin D and diabetes have a rocky relationship, but new insight was revealed at the American Diabetes Association (ADA 2016) 76th Scientific Sessions in New Orleans, Louisiana.

What happens when a patient with type 2 diabetes uses both a potassium (K)-sparing agent and sodium-glucose co-transporter 2 (SGLT2) inhibitor at the same time?

Two approaches to replace deteriorating beta cells in patients with type 1 diabetes were presented at the ADA’s Scientific Sessions.

Statistics coming from controlled trials can be challenging to apply to the real-world. But a new study assessing the use of dapagliflozin for type 2 diabetes in real clinical use yielded important insight.

New research presented at the American Diabetes Association (ADA 2016) 76th Scientific Sessions in New Orleans, Louisiana makes a case for autologous transplantation.

Pig cell transplantation could take the place of a blood glucose level-improving surgery for patients with type 1 diabetes.

Study results show that patients with diabetic macular edema are more likely to improve with treatment by a combination of ranibizumab and AKB-9778, as compared to treatment with either alone.

Three new studies highlight promising diabetes drug treatments to help patients who struggle with severe hyperglycemia.

As adjunctive therapy with insulin in poorly controlled type 2 diabetes, which drugs proved more effective – SGLT2 inhibitors or DPP-4 inhibitors?

Research suggests that lipid screening appears to remain particularly underutilized in adults taking antipsychotic medications, despite improvements in recent years in the use of diabetes screening in this patient population.

Does insulin in conjunction with metformin have the potential to reduce all-cause mortality in patients with type 2 diabetes?

Researchers investigated the risk of hospitalization or death in older patients with type 2 diabetes initiating basal insulin treatment.

New consensus guidelines for the treatment of type 2 diabetes mellitus (T2DM) recommend, for the first time, that metabolic surgery be recommended or considered as an intervention for many obese patients.

A network meta-analysis compared GLP-1 receptor agonists to traditional anti-diabetes drugs based on hypoglycemia incidence, HbA1c goals, and more.

Researchers compared the safety and efficacy of a GLP-1 receptor agonist in patients aged 65 years or older to those under 65 years.

Does an antidiabetic therapy delivery system that would provide 100% medication adherence sound too good to be true?

Investigators from Washington University and Harvard University have used stem cells derived from patients with type 1 diabetes mellitus to produce cells that secrete insulin in both cultures and mice.

When treating patients with a variety of conditions it can be easy for the lines of care to be blurred, this is particularly true when treating patients with conditions like diabetes and heart failure among others.

Treating patients with diabetes can be enough of a challenge for doctors, add in the comorbidity of cardiac conditions as well and the work gets that much harder to navigate for even the most veteran clinicians.

Changes in the composition of the gut microbiome may contribute to the development of anti-islet autoimmunity, according to the BABYDIET study.

Patients with diabetes face several challenges when it comes to coronary surgery success for numerous conditions. A recent study looked at the impact diabetes has on the success of coronary bypass grafts.

Several trials are due to be completed this year, bringing the hope that at least one artificial pancreas system will come to market in 2017.

As with all surgical procedures, there are risks that come with gastric bypass surgery. While the procedure itself is not new, there is work being done to make it more effective and longer lasting for patients who utilize this valuable weight loss option.

Obesity remains a growing problem and while gastric bypass surgery has become a viable option for many patients, there is still work being done to improve the procedure.

In this Medical News Minute, Dr. Bobby Lazzara examines a phase 3 study of transplanted purified human pancreatic islets in type 1 diabetes patients.

Prevalence of type 1 diabetes has risen in many parts of the world. In one way, that may be a good thing. It could mean that people with diabetes are living longer.